07/28/2025 10:00
BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Neoadjuvant/Adjuvant NSCLC Treatment

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending approval of TEVIMBRA® (tislelizumab), in combination with platinum-containing chemotherapy as neoadjuvant treatment and then continued as monotherapy as adjuvant treatment, for the treatment of adult patients with resectable non-small cell lung cancer (NSCLC)...

07/31/2025 10:30
Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the second quarter 2025 and provided an update on recent progress across its business. “With the recent positive 6-week primary endpoint from our first COMP360 Phase 3 study and the prior positive Phase 2b study, we have now delivered clinically meaningful and highly statistically significant top-line resu...

09/09/2025 07:30
Autel Energy Collaborates with Phoenix Contact to Integrate High-Current CCS2 Technology into New Megawatt-Class Charging System

As part of its global product launch event “Infinite Power – Starting from Zero,” Autel Energy introduced a high-power charging system from the MaxiCharger DT1000 series, integrating Phoenix Contact’s latest 1,000A liquid-cooled CCS Type 2 cable and connector system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909054584/en/Autel Energy showcased the MaxiCharger DT1000 terminal integrating Phoenix Contact’s latest liquid-cooled...

09/09/2025 07:38
Sisvel Appoints IP Leader to Head China Business and Establish Shenzhen Office

Sisvel has appointed Yixiong Zou to lead its operations in China. He will be responsible for steering the company’s licensing, programme management and business development efforts in the country, and will manage a new Sisvel office to be established in Shenzhen. Mr Zou joins the company as Managing Director, China and is the first person to hold this title. His appointment reflects the importance that Sisvel attaches to the Chinese market. In a career spanning more than 25 years, Mr Zou ha...

09/03/2025 11:59
NuScale Proudly Supports TVA and ENTRA1 Energy Announcement of Landmark 6-Gigawatt Small Module Reactor (SMR) Deployment Program

NuScale Power Corporation (NYSE: SMR), the industry-leading provider of proprietary and innovative advanced small modular reactor (SMR) nuclear technology, today announced its strong support for ENTRA1 Energy’s American landmark agreement with the Tennessee Valley Authority (TVA) to deploy up to 6 gigawatts of NuScale SMR capacity across TVA’s seven-state service region—the largest SMR deployment program in U.S. history. This press release features multimedia. View the full release here: https...